Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 3Not yet recruiting 2Unknown 1

Sponsor Class

OTHER 6OTHER_GOV 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Thoracic 1

Conditions

Breast Neoplasms 15Neoplasms 12Carcinoma, Hepatocellular 12Uterine Cervical Neoplasms 10Esophageal Neoplasms 10Nasopharyngeal Carcinoma 8Carcinoma, Non-Small-Cell Lung 8Ovarian Neoplasms 6Carcinoma, Ovarian Epithelial 6Melanoma 5Lung Neoplasms 5Colorectal Neoplasms 5Thyroid Cancer, Papillary 4Stomach Neoplasms 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Motor Activity 4Hematologic Neoplasms 4Fallopian Tube Neoplasms 4Endometrial Neoplasms 4Colonic Neoplasms 4Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Pain 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Esophageal Squamous Cell Carcinoma 3Uveal Melanoma 2Thyroid Neoplasms 2Skin Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER_GOV × Meningeal Carcinomatosis × Clear all
NCT06971406 2025-05-14

FLAME-1

Henan Cancer Hospital

Phase 2 Not yet recruiting
100 enrolled
CNSThoracic

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT06441045 2024-06-04

Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKI

Fujian Cancer Hospital

Phase 2 Not yet recruiting
112 enrolled
CNS

Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡